Risk factors for recurrence in patients with stage IB, IIA, and IIB cervical carcinoma after radical hysterectomy and postoperative pelvic irradiation

被引:46
作者
Lin, HH
Cheng, WF
Chan, KWA
Chang, DY
Chen, CK
Huang, SC
机构
[1] NATL TAIWAN UNIV,COLL MED,DEPT OBSTET & GYNECOL,TAIPEI 10764,TAIWAN
[2] NATL TAIWAN UNIV,COLL PUBL HLTH,DEPT EPIDEMIOL,TAIPEI 10764,TAIWAN
关键词
D O I
10.1016/0029-7844(96)00145-7
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: To identify risk factors for cancer recurrence in patients with stage IB, IIA, and IIB cervical carcinoma after abdominal radical hysterectomy with pelvic lymph node dissection and postoperative pelvic irradiation. Methods: One hundred and eighty-seven patients with cervical carcinoma stage IB (n = 63), IIA (n = 43), and IIB (n = 81) disease who received abdominal radical hysterectomy with pelvic lymph node dissection and postoperative pelvic irradiation were followed-up for 2-10 years. The histologic type, grade, lymphovascular tumor emboli, tumor size, invasion sites, deep cervical stromal invasion, and pelvic lymph node metastases were assessed for correlation with cancer recurrence. Results: Recurrence occurred in 45 cases (24%), of whom 40 had died of the disease at the 5-year follow-up period. Univariate proportional hazards analysis revealed that the significant risk factors were adenocarcinoma, bulky tumor size (4 cm or greater), lymphovascular tumor emboli, deep cervical stromal invasion, and lymph node metastases, especially iliac nodal metastases and bilateral nodal metastases. Multivariate proportional hazards analysis showed that bulky tumor size (hazard ratio 2.34), tumor emboli (hazard ratio 2.74) and iliac nodal metastases (hazard ratio 5.31) remained significant risk factors. In contrast, no deaths occurred in the other 142 cases who did not have recurrence. Conclusion: This retrospective study suggests that stage IB, IIA,and IIB cervical carcinoma cases with the above-mentioned pathologic factors are at higher risk of recurrence after abdominal radical hysterectomy with pelvic lymph node dissection and postoperative pelvic irradiation.
引用
收藏
页码:274 / 279
页数:6
相关论文
共 32 条
[11]  
2-R
[12]  
INOUE T, 1984, CANCER, V54, P1714, DOI 10.1002/1097-0142(19841015)54:8<1714::AID-CNCR2820540838>3.0.CO
[13]  
2-S
[14]   COMPLICATIONS IN PATIENTS RECEIVING BOTH IRRADIATION AND RADICAL HYSTERECTOMY FOR CARCINOMA OF THE UTERINE CERVIX [J].
JACOBS, AJ ;
PEREZ, CA ;
CAMEL, HM ;
KAO, MS .
GYNECOLOGIC ONCOLOGY, 1985, 22 (03) :273-280
[15]   ADJUVANT CHEMOTHERAPY AND RADIATION IN PATIENTS WITH POOR PROGNOSTIC STAGE-IB/IIA CERVICAL-CANCER [J].
KILLACKEY, MA ;
BOARDMAN, L ;
CARROLL, DS .
GYNECOLOGIC ONCOLOGY, 1993, 49 (03) :377-379
[16]   2-YEAR SURVIVAL - PREOPERATIVE ADJUVANT CHEMOTHERAPY IN THE TREATMENT OF CERVICAL-CANCER STAGE-IB AND STAGE-II WITH BULKY TUMOR [J].
KIM, DS ;
MOON, H ;
KIM, KT ;
HWANG, YY ;
CHO, SH ;
KIM, SR .
GYNECOLOGIC ONCOLOGY, 1989, 33 (02) :225-230
[17]   PREOPERATIVE ADJUVANT CHEMOTHERAPY IN THE TREATMENT OF CERVICAL-CANCER STAGE-IB, STAGE-IIA AND STAGE-IIB WITH BULKY TUMOR [J].
KIM, DS ;
MOON, H ;
HWANG, YY ;
CHO, SH .
GYNECOLOGIC ONCOLOGY, 1988, 29 (03) :321-332
[18]   ADJUVANT POSTOPERATIVE RADIATION-THERAPY FOLLOWING RADICAL HYSTERECTOMY IN STAGE-IB CA OF THE CERVIX - ANALYSIS OF TREATMENT FAILURE [J].
KIM, RY ;
SALTER, MM ;
SHINGLETON, HM .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1988, 14 (03) :445-449
[19]  
Kuehnle H, 1992, Semin Oncol, V19, P94
[20]   ADJUVANT CHEMOTHERAPY AFTER RADICAL HYSTERECTOMY FOR CERVICAL-CARCINOMA [J].
LAI, CH ;
LIN, TS ;
SOONG, YK ;
CHEN, HF .
GYNECOLOGIC ONCOLOGY, 1989, 35 (02) :193-198